1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics, October 2016 (p20)

Biopharmaceutical Analysis & Statistics, October 2016 (p20)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

All regions

571-600 of about 1700 reports

Purchase Reports From Reputable Market Research Publishers

Biomedical Structures LLC - Medical Equipment - Deals and Alliances Profile

Biomedical Structures LLC - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2016
  • by GlobalData

Summary Biomedical Structures LLC (BMS) is a medical device company that designs, develops and manufactures medical textiles. The company manufacturers devices and structures including knitted, braided, ...

  • Industries : Medical Device
Alliqua BioMedical, Inc. (ALQA) - Medical Equipment - Deals and Alliances Profile

Alliqua BioMedical, Inc. (ALQA) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2016
  • by GlobalData

Summary Alliqua BioMedical, Inc. (Alliqua BioMedical) formerly HepaLife Technologies Inc. is a medical device company that offers wound care solutions. The company offers wound care, transdermal drug delivery, ...

  • Industries : Biopharmaceutical
Adhezion Biomedical, LLC - Medical Equipment - Deals and Alliances Profile

Adhezion Biomedical, LLC - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2016
  • by GlobalData

Summary Adhezion Biomedical, LLC (Adhezion) is a medical device company that develops and commercializes cyanoacrylate based surgical, wound management and infection prevention technologies. The company ...

  • Industries : Medical Device
Arbutus Biopharma Corporation (ABUS) - Financial and Strategic SWOT Analysis Review

Arbutus Biopharma Corporation (ABUS) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • October 2016
  • by GlobalData

Arbutus Biopharma Corporation (ABUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled ...

  • Industries : Biopharmaceutical
Industrial Enzymes Market by Type, Application, Source, and Region - Global Forecast to 2022

Industrial Enzymes Market by Type, Application, Source, and Region - Global Forecast to 2022

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

“Industrial enzymes market projected to grow at a CAGR of 5.8%.” The industrial enzymes market is projected to grow at a CAGR of 5.8% from 2017 and reach USD 6.30 billion by 2022. The demand for industrial ...

  • Industries : Chemical
  • Countries : World, Asia, Europe
Global Protein Hydrolysate Ingredient Market Research Report 2016

Global Protein Hydrolysate Ingredient Market Research Report 2016

  • $ 2850
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Protein Hydrolysate Ingredient Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Protein Hydrolysate Ingredient industry, ...

  • Industries : Biopharmaceutical
  • Countries : World, Europe, Asia, North America
Hepatitis D - Pipeline Review, H2 2016

Hepatitis D - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Hepatitis D - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis D - Pipeline Review, H2 2016, provides an overview of the Hepatitis ...

  • Industries : Pathology
  • Countries : United States, World
Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline Review, H2 2016

Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline ...

  • Industries : Pathology, Cancer
  • Countries : World, Spain, United States
Advanced Enzyme Technologies Ltd

Advanced Enzyme Technologies Ltd

  • $ 99
  • Company report
  • October 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Advanced Enzyme Technologies Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biopharmaceutical
  • Countries : World, India
Glycoprotein 41 (gp41) - Pipeline Review, H2 2016

Glycoprotein 41 (gp41) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Glycoprotein 41 (gp41) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Glycoprotein 41 (gp41) - Pipeline Review, H2 2016’, provides in depth analysis on Glycoprotein 41 (gp41) targeted ...

  • Industries : Pathology
  • Countries : United States
Theravance Biopharma, Inc. (TBPH) - Financial and Strategic SWOT Analysis Review

Theravance Biopharma, Inc. (TBPH) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Theravance Biopharma, Inc. (Theravance) which discovers and develops novel medicines for various diseases.It offers a commercial product, telavancin which is a dual mechanism antibiotic.The company’s ...

  • Industries : Biopharmaceutical
Eiger BioPharmaceuticals, Inc. (EIGR) - Financial and Strategic SWOT Analysis Review

Eiger BioPharmaceuticals, Inc. (EIGR) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Eiger BioPharmaceuticals, Inc. (Eiger) formerly Celladon Corporation is a clinical stage biopharmaceutical company that discovers and develops novel drugs for the treatment of orphan diseases. ...

  • Industries : Biopharmaceutical
European Erythropoietin Market Outlook 2022

European Erythropoietin Market Outlook 2022

  • $ 1500
  • Industry report
  • October 2016
  • by RNCOS

Erythropoietin drugs are protein therapeutics, which is used to treat various types of anaemia. These drugs play a significant role in treating CKD related anaemia and cancer related anaemia. Since its ...

  • Industries : Biopharmaceutical
  • Countries : Europe
Provectus Biopharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review

Provectus Biopharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Provectus Biopharmaceuticals, Inc. (Provectus), formerly Provectus pharmaceuticals, Inc. is a biopharmaceutical company that develops pharmaceuticals for oncology and dermatology indications. The ...

  • Industries : Biopharmaceutical
  • Countries : United States
RedHill Biopharma Ltd. (RDHL) - Financial and Strategic SWOT Analysis Review

RedHill Biopharma Ltd. (RDHL) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary RedHill Biopharma Ltd. (RedHill) is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs for the treatment of inflammatory and gastrointestinal ...

  • Industries : Biopharmaceutical
Alder Biopharmaceuticals Inc. (ALDR) - Financial and Strategic SWOT Analysis Review

Alder Biopharmaceuticals Inc. (ALDR) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Alder Biopharmaceuticals Inc. (Alder) develops, produces and markets monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease and autoimmune and inflammatory diseases. ...

  • Industries : Biopharmaceutical
Shin Nippon Biomedical Laboratories, Ltd. (2395) - Financial and Strategic SWOT Analysis Review

Shin Nippon Biomedical Laboratories, Ltd. (2395) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by Global Data

Summary Shin Nippon Biomedical Laboratories, Ltd. (SNBL) is a healthcare service provider that provides drug and clinical development service to biopharmaceutical companies. Its preclinical services include ...

  • Industries : Biopharmaceutical
Single-use Bioprocessing Market by Product, Application, End User - Global Forecast to 2021

Single-use Bioprocessing Market by Product, Application, End User - Global Forecast to 2021

  • $ 6328
  • Industry report
  • October 2016
  • by MarketsandMarkets

Rising Biopharmaceutical Demand and Increasing Investments in R&D Activities Drive Growth of the Single-use Bioprocessing Market The global single-use bioprocessing market is projected to reach USD 5.44 ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : World, North America, Asia
Single-use Bioreactor Market by Product, Cell, Technology, Application, End User - Global Forecast to 2021

Single-use Bioreactor Market by Product, Cell, Technology, Application, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global single-use bioreactors market is projected to reach USD 1,085.7 million by 2021 from USD 408.4 million in 2016, growing at a CAGR of 21.6% during the forecast period (2016–2021). In this report, ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : World, Europe, North America
Hemispherx Biopharma, Inc. (HEB) - Financial and Strategic SWOT Analysis Review

Hemispherx Biopharma, Inc. (HEB) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • October 2016
  • by GlobalData

Hemispherx Biopharma, Inc. (HEB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled ...

  • Industries : Biopharmaceutical
Tangential Flow Filtration Market Product, Membrane Material, Technology, Pore Size, Application Global Forecast to 2021

Tangential Flow Filtration Market Product, Membrane Material, Technology, Pore Size, Application Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The tangential flow filtration market is projected to reach USD 1,005.0 million by 2021 USD 554.7 million in 2016, growing at a CAGR of 12.6% during the forecast period (2016–2021). Growth in the bi ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : North America, World
Global Biosimilars Market and Forecast (By Product Type, Applications, Country Wise and Companies) to 2021 and Biosimilars Approved and Pipeline Analysis

Global Biosimilars Market and Forecast (By Product Type, Applications, Country Wise and Companies) to 2021 and Biosimilars Approved and Pipeline Analysis

  • $ 1350
  • Industry report
  • October 2016
  • by Igate Research

The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and growing investment and deal making activity globally. The ...

  • Industries : Biopharmaceutical, Generic Drug, Biotechnology, Pharmaceutical
  • Countries : World
Global Nucleic Acid Molecule Hybridization Apparatus Market Research Report 2016

Global Nucleic Acid Molecule Hybridization Apparatus Market Research Report 2016

  • $ 2850
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Nucleic Acid Molecule Hybridization Apparatus Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Nucleic Acid Molecule Hybridization ...

  • Industries : Biopharmaceutical
  • Countries : World, Europe, Asia, North America
Enbrel Biosimilars Clinical Trial Insight

Enbrel Biosimilars Clinical Trial Insight

  • $ 1500
  • Industry report
  • October 2016
  • by PNS Pharma

“Enbrel Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 36 biosimilars version of Enbrel drug in clinical pipeline. More than 5 of these biosimilars ...

  • Industries : Biopharmaceutical
Lantus (Insulin Glargine) Biosimilar Clinical Trial & Opportunity Insight

Lantus (Insulin Glargine) Biosimilar Clinical Trial & Opportunity Insight

  • $ 1000
  • Industry report
  • October 2016
  • by PNS Pharma

“Lantus (Insulin Glargine) Biosimilar Clinical Trial & Opportunity Insight” report by PNS Pharma gives comprehensive clinical insight on 37 biosimilar version of Lantus drug in clinical pipeline. Currently ...

  • Industries : Biopharmaceutical, Therapy
Insulin Biosimilars - Global Market Outlook (2016-2022)

Insulin Biosimilars - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...

  • Industries : Biopharmaceutical, Generic Drug, Pharmaceutical
  • Countries : World, Asia, Europe, North America
Remicade (Infliximab) Biosimilar Clinical Trial Insight

Remicade (Infliximab) Biosimilar Clinical Trial Insight

  • $ 1200
  • Industry report
  • October 2016
  • by PNS Pharma

“Remicade (Infliximab) Biosimilar Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 17 biosimilar version of Remicade drug in clinical pipeline. Currently there are ...

  • Industries : Therapy, Biopharmaceutical, Oncology
Humira Biosimilars Clinical Trial Insight

Humira Biosimilars Clinical Trial Insight

  • $ 1500
  • Industry report
  • October 2016
  • by PNS Pharma

“Humira Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 33 biosimilars version of Humira drug in clinical pipeline. More than 10 of these biosimilars ...

  • Industries : Therapy, Biopharmaceutical, Oncology
  • Countries : United States
Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight

Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight

  • $ 1500
  • Industry report
  • October 2016
  • by PNS Pharma

“Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 37 biosimilar version of Herceptin drug in clinical pipeline. Currently there ...

  • Industries : Therapy, Biopharmaceutical, Oncology
Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

  • $ 2995
  • Industry report
  • October 2016
  • by Currentpartnering

The Global Gene Therapy Partnering Agreements 2010-2016 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. ...

  • Industries : Biological Therapy, Pathology, Healthcare, Biotechnology, Therapy
  • Countries : United States
About 4200 reports

Download Unlimited Documents from Trusted Public Sources

Protein Industry in the US

  • February 2017
    12 pages
  • Protein  

  • United States  

View report >

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.